Microsoft Announces $60 Billion Buyback, Raises Dividend 10% - Bloomberg
Microsoft Corp. unveiled a new $60 billion stock-buyback program, matching its largest-ever repurchase authorization, and raised its quarter...
Microsoft Corp. unveiled a new $60 billion stock-buyback program, matching its largest-ever repurchase authorization, and raised its quarter...
Starbucks said on Monday that its North America CEO, Michael Conway, had decided to retire after about 11 years at the coffee chain....
The Amazon CEO's announcement on Monday, ordering the end to pandemic-era hybrid work and flattening management, is a very public and calcul...
Intel announced it'll pause its chip-making plans in Poland and Germany -- and expand a deal with AWS to build custom chips, including an AI...
Technology stocks benefit the most from low interest rates, conventional market wisdom says....
TORONTO — Health Canada authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of th...
Health Canada has authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus....
The mRNA vaccine, called Spikevax, has been reformulated to target the KP.2 subvariant of Omicron....
Health Canada has authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of the virus. The...
The KP.3 variant of SARS-CoV-2 is dominating in Canada right now, accounting for the majority of the COVID-19 cases in the country....
![TORONTO — Health Canada authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday. The mRNA vaccine, called Spikevax, has been reformulated to target the KP.2 subvariant of Omicron, the agency said. It replaces the previous version of the vaccine that was released last year, which targeted the XBB.1.5 […]](/media/blogimages/Health-Canada-approves-updated-Moderna-COVID-19-vaccine113f6f38-90d7-4476-9fb_ThEbspp.jpg)
![Health Canada has authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA vaccine, called Spikevax, has been reformulated to target the KP.2 subvariant of Omicron. It will replace the previous version of the vaccine that was released a year ago, which targeted the XBB.1.5 subvariant of Omicron. Health […]](/media/blogimages/Health-Canada-approves-updated-Moderna-COVID-19-vaccine2ddc141a-30c3-48c3-917_Gzy7N6a.jpg)
